Colony-stimulating factors and neutropenia: intersection of data and clinical relevance.

Abstract

Until recently, neutropenia was regarded as an unalterable consequence of many cancer chemotherapies. Oncologists have long realized that the depth and duration of neutropenia are the primary risk factors for the development of infections that could seriously undermine cancer treatment (/). The morbidity and mortality associated with these infectious… (More)

Topics

Cite this paper

@article{Freifeld1995ColonystimulatingFA, title={Colony-stimulating factors and neutropenia: intersection of data and clinical relevance.}, author={Allison Freifeld and P. Pizzo}, journal={Journal of the National Cancer Institute}, year={1995}, volume={87 11}, pages={781-2} }